SCHEMBL19685955

SCHEMBL19685955

Cc1ccc2c(c1)C1(c3ccccc3-c3ccccc31)c1cc(C)ccc1N2c1ccc2oc(C)cc(=O)c2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.40
KDM4E B2RXH2 4/20 0.39
MAPT P10636 4/20 0.39
ALDH1A1 P00352 3/20 0.39
TP53 P04637 3/20 0.39
CYP3A4 P08684 3/20 0.39
HPGD P15428 2/20 0.39
HSD17B10 Q99714 2/20 0.39
POLB P06746 1/20 0.39
MAPK1 P28482 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HTT P42858 1/20 0.35
CYP1A1 P04798 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP1B1 Q16678 1/20 0.34
PGR P06401 1/20 0.34
RECQL P46063 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19685951 0.92 ALDH1A1 (0.36) ACHEKDM4EMAPTALDH1A1TP53
SCHEMBL19686064 0.91 ACHE (0.43) ACHEKDM4EMAPTALDH1A1TP53
SCHEMBL19685953 0.91 ACHE (0.40) ACHEKDM4EMAPTALDH1A1TP53
SCHEMBL19685952 0.83 ALDH1A1 (0.34) ACHEKDM4EMAPTALDH1A1TP53
SCHEMBL19685900 0.82 ACHE (0.36) ACHEKDM4EMAPTALDH1A1TP53
SCHEMBL19685956 0.82 ACHE (0.41) ACHEKDM4EMAPTALDH1A1TP53
SCHEMBL19685954 0.81 ACHE (0.43) ACHEKDM4EMAPTALDH1A1TP53
SCHEMBL17752281 0.81 PTGER4 (0.42) KDM4EMAPTALDH1A1CYP3A4HPGD
SCHEMBL19685972 0.81 ACHE (0.38) ACHEKDM4EMAPTALDH1A1TP53
SCHEMBL19686065 0.80 ACHE (0.46) ACHEKDM4EMAPTALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10714693-B2 Polycyclic compound and organic electroluminescence device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-07-14 US disclosed
US-20170352817-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2017-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10714693-B2 Polycyclic compound and organic electroluminescence device including the same CYC1, CCNA1, CYCS ACHE 3408/4885KDM4E 1138/4885MAPT 4713/4885
US-20170352817-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME CYC1, CCNA1, CYCS ACHE 3408/4885KDM4E 1138/4885MAPT 4713/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.